|
|
 |
| |
|
|
|
|
|
|
|
 |
|
 |
|
One 0.5mL dose contains:
Active ingredient : 10µg of capsular oligosaccharide of H.influenzae type b conjugated to approx 25µg of CRM197 protein |
Active immunization of children from 2 months to 5 years of age against invasive caused by H.influenzae type b
- Primary vaccination: administration of three doses at two, four, six months of age.
- Booster vaccination: administration of one dose at 16~20 months
- FirstHib should be administered intramuscularly.
1. First prefilled syringe type Hib vaccine in Korea.
2. It is producted in the PFS production line that is first established in Korea and the largest scale.
3. Adjuvanted for better protection
4. Liquid Type vaccine and high convenience.
5. No preservatives. |
|
 |
|
|
|
